Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

A degradatory fate for CCR4 suggests a primary role in Th2 inflammation.

Anderson CA, Patel P, Viney JM, Phillips RM, Solari R, Pease JE.

J Leukoc Biol. 2020 Feb 13. doi: 10.1002/JLB.2A0120-089RR. [Epub ahead of print]

PMID:
32052476
2.

Identification of regulators of the myofibroblast phenotype of primary dermal fibroblasts from early diffuse systemic sclerosis patients.

Chadli L, Sotthewes B, Li K, Andersen SN, Cahir-McFarland E, Cheung M, Cullen P, Dorjée A, de Vries-Bouwstra JK, Huizinga TWJ, Fischer DF, DeGroot J, Viney JL, Zheng TS, Aarbiou J, Gardet A.

Sci Rep. 2019 Mar 14;9(1):4521. doi: 10.1038/s41598-019-41153-w.

3.

Pristane-Accelerated Autoimmune Disease in (SWR X NZB) F1 Mice Leads to Prominent Tubulointerstitial Inflammation and Human Lupus Nephritis-Like Fibrosis.

Gardet A, Chou WC, Reynolds TL, Velez DB, Fu K, Czerkowicz JM, Bajko J, Ranger AM, Allaire N, Kerns HM, Ryan S, Legault HM, Dunstan RW, Lafyatis R, Lukashev M, Viney JL, Browning JL, Rabah D.

PLoS One. 2016 Oct 19;11(10):e0164423. doi: 10.1371/journal.pone.0164423. eCollection 2016.

4.

Discovery of biaryl carboxylamides as potent RORγ inverse agonists.

Chao J, Enyedy I, Van Vloten K, Marcotte D, Guertin K, Hutchings R, Powell N, Jones H, Bohnert T, Peng CC, Silvian L, Hong VS, Little K, Banerjee D, Peng L, Taveras A, Viney JL, Fontenot J.

Bioorg Med Chem Lett. 2015 Aug 1;25(15):2991-7. doi: 10.1016/j.bmcl.2015.05.026. Epub 2015 May 23.

PMID:
26048806
5.

Anti-BDCA2 monoclonal antibody inhibits plasmacytoid dendritic cell activation through Fc-dependent and Fc-independent mechanisms.

Pellerin A, Otero K, Czerkowicz JM, Kerns HM, Shapiro RI, Ranger AM, Otipoby KL, Taylor FR, Cameron TO, Viney JL, Rabah D.

EMBO Mol Med. 2015 Apr;7(4):464-76. doi: 10.15252/emmm.201404719.

6.

GPR15: a tale of two species.

Bilsborough J, Viney JL.

Nat Immunol. 2015 Feb;16(2):137-9. doi: 10.1038/ni.3084. No abstract available.

PMID:
25594457
7.

CXCR3 antagonist VUF10085 binds to an intrahelical site distinct from that of the broad spectrum antagonist TAK-779.

Nedjai B, Viney JM, Li H, Hull C, Anderson CA, Horie T, Horuk R, Vaidehi N, Pease JE.

Br J Pharmacol. 2015 Apr;172(7):1822-33. doi: 10.1111/bph.13027. Epub 2015 Feb 10.

8.

Immune modulation by butyrophilins.

Arnett HA, Viney JL.

Nat Rev Immunol. 2014 Aug;14(8):559-69. doi: 10.1038/nri3715. Review.

PMID:
25060581
9.

Distinct conformations of the chemokine receptor CCR4 with implications for its targeting in allergy.

Viney JM, Andrew DP, Phillips RM, Meiser A, Patel P, Lennartz-Walker M, Cousins DJ, Barton NP, Hall DA, Pease JE.

J Immunol. 2014 Apr 1;192(7):3419-27. doi: 10.4049/jimmunol.1300232. Epub 2014 Feb 21.

10.

Genetic architecture of human fibrotic diseases: disease risk and disease progression.

Gardet A, Zheng TS, Viney JL.

Front Pharmacol. 2013 Dec 18;4:159. doi: 10.3389/fphar.2013.00159. Review.

11.

Butyrophilin-like 2 modulates B7 costimulation to induce Foxp3 expression and regulatory T cell development in mature T cells.

Swanson RM, Gavin MA, Escobar SS, Rottman JB, Lipsky BP, Dube S, Li L, Bigler J, Wolfson M, Arnett HA, Viney JL.

J Immunol. 2013 Mar 1;190(5):2027-35. doi: 10.4049/jimmunol.1201760. Epub 2013 Jan 28.

12.

Human labour is associated with a decline in myometrial chemokine receptor expression: the role of prostaglandins, oxytocin and cytokines.

Hua R, Pease JE, Cheng W, Sooranna SR, Viney JM, Nelson SM, Myatt L, Bennett PR, Johnson MR.

Am J Reprod Immunol. 2013 Jan;69(1):21-32. doi: 10.1111/aji.12025. Epub 2012 Oct 9.

PMID:
23043391
13.

Structure of the cyanobacterial Magnesium Chelatase H subunit determined by single particle reconstruction and small-angle X-ray scattering.

Qian P, Marklew CJ, Viney J, Davison PA, Brindley AA, Söderberg C, Al-Karadaghi S, Bullough PA, Grossmann JG, Hunter CN.

J Biol Chem. 2012 Feb 10;287(7):4946-56. doi: 10.1074/jbc.M111.308239. Epub 2011 Dec 15.

14.

Stretch and inflammatory cytokines drive myometrial chemokine expression via NF-κB activation.

Hua R, Pease JE, Sooranna SR, Viney JM, Nelson SM, Myatt L, Bennett PR, Johnson MR.

Endocrinology. 2012 Jan;153(1):481-91. doi: 10.1210/en.2011-1506. Epub 2011 Nov 1.

PMID:
22045664
15.

The tale of TL1A in inflammation.

Hsu H, Viney JL.

Mucosal Immunol. 2011 Jul;4(4):368-70. doi: 10.1038/mi.2011.20. Epub 2011 May 4. Review.

PMID:
21544073
16.

Welcome to the fourth year of Mucosal Immunology!

Kelsall BL, Viney J, Garside P.

Mucosal Immunol. 2011 Jan;4(1):2-3. doi: 10.1038/mi.2010.78. No abstract available.

PMID:
21191364
17.

Metastatic carcinoid presenting as a breast lesion.

Geyer HL, Viney J, Karlin N.

Curr Oncol. 2010 Nov;17(6):73-7.

18.

A metabolic signature of long life in Caenorhabditis elegans.

Fuchs S, Bundy JG, Davies SK, Viney JM, Swire JS, Leroi AM.

BMC Biol. 2010 Feb 10;8:14. doi: 10.1186/1741-7007-8-14.

19.

Gatekeepers of intestinal inflammation.

Arnett HA, Viney JL.

Inflamm Res. 2010 Jan;59(1):1-14. Review.

PMID:
20066780
20.

Methods of inducing inflammatory bowel disease in mice.

Maxwell JR, Brown WA, Smith CL, Byrne FR, Viney JL.

Curr Protoc Pharmacol. 2009 Dec;Chapter 5:Unit5.58. doi: 10.1002/0471141755.ph0558s47.

PMID:
22294404
21.

Overview of mouse models of inflammatory bowel disease and their use in drug discovery.

Maxwell JR, Viney JL.

Curr Protoc Pharmacol. 2009 Dec;Chapter 5:Unit5.57. doi: 10.1002/0471141755.ph0557s47. Review.

PMID:
22294403
22.

Recent developments in IBD and the B7 family of costimulatory molecules.

Arnett HA, Viney JL.

Curr Opin Investig Drugs. 2009 May;10(5):443-51. Review.

PMID:
19431077
23.

Regulation of costimulation in the era of butyrophilins.

Arnett HA, Escobar SS, Viney JL.

Cytokine. 2009 Jun;46(3):370-5. doi: 10.1016/j.cyto.2009.03.009. Epub 2009 Apr 19. Review.

PMID:
19380239
24.

Serum biomarkers in a mouse model of bacterial-induced inflammatory bowel disease.

Torrence AE, Brabb T, Viney JL, Bielefeldt-Ohmann H, Treuting P, Seamons A, Drivdahl R, Zeng W, Maggio-Price L.

Inflamm Bowel Dis. 2008 Apr;14(4):480-90.

PMID:
18095317
25.

Direct measurement of metal-ion chelation in the active site of the AAA+ ATPase magnesium chelatase.

Viney J, Davison PA, Hunter CN, Reid JD.

Biochemistry. 2007 Nov 6;46(44):12788-94. Epub 2007 Oct 12.

PMID:
17929947
26.

Considerations for the sensible use of rodent models of inflammatory disease in predicting efficacy of new biological therapeutics in the clinic.

Arnett HA, Viney JL.

Adv Drug Deliv Rev. 2007 Sep 30;59(11):1084-92. Epub 2007 Aug 16. Review.

PMID:
17804112
27.

BTNL2, a butyrophilin/B7-like molecule, is a negative costimulatory molecule modulated in intestinal inflammation.

Arnett HA, Escobar SS, Gonzalez-Suarez E, Budelsky AL, Steffen LA, Boiani N, Zhang M, Siu G, Brewer AW, Viney JL.

J Immunol. 2007 Feb 1;178(3):1523-33.

28.

From model to mechanism: lessons of mice and men in the discovery of protein biologicals for the treatment of inflammatory bowel disease.

Bilsborough J, Viney JL.

Expert Opin Drug Discov. 2006 Jun;1(1):69-83. doi: 10.1517/17460441.1.1.69.

PMID:
23506033
29.

Mouse models of inflammatory bowel disease.

Byrne FR, Viney JL.

Curr Opin Drug Discov Devel. 2006 Mar;9(2):207-17. Review.

PMID:
16566291
30.

The maize Oil yellow1 (Oy1) gene encodes the I subunit of magnesium chelatase.

Sawers RJ, Viney J, Farmer PR, Bussey RR, Olsefski G, Anufrikova K, Hunter CN, Brutnell TP.

Plant Mol Biol. 2006 Jan;60(1):95-106.

PMID:
16463102
31.

Dual infection with Helicobacter bilis and Helicobacter hepaticus in p-glycoprotein-deficient mdr1a-/- mice results in colitis that progresses to dysplasia.

Maggio-Price L, Bielefeldt-Ohmann H, Treuting P, Iritani BM, Zeng W, Nicks A, Tsang M, Shows D, Morrissey P, Viney JL.

Am J Pathol. 2005 Jun;166(6):1793-806.

32.
33.

In vivo enhancement of dendritic cell function.

Bilsborough J, Viney JL.

Ann N Y Acad Sci. 2004 Dec;1029:83-7. Review.

PMID:
15681747
34.

Out, out darn toxin: the role of MDR in intestinal homeostasis.

Bilsborough J, Viney JL.

Gastroenterology. 2004 Jul;127(1):339-40. Review. No abstract available.

PMID:
15236205
35.

Gastrointestinal dendritic cells play a role in immunity, tolerance, and disease.

Bilsborough J, Viney JL.

Gastroenterology. 2004 Jul;127(1):300-9. Review.

PMID:
15236195
36.
37.

High antigen dose and activated dendritic cells enable Th cells to escape regulatory T cell-mediated suppression in vitro.

George TC, Bilsborough J, Viney JL, Norment AM.

Eur J Immunol. 2003 Feb;33(2):502-11.

38.

GM-CSF treatment for Crohn's disease: a stimulating new therapy?

Wilk JN, Viney JL.

Curr Opin Investig Drugs. 2002 Sep;3(9):1291-6. Review.

PMID:
12498002
40.

Defining the roles of perforin, Fas/FasL, and tumour necrosis factor alpha in T cell induced mucosal damage in the mouse intestine.

Merger M, Viney JL, Borojevic R, Steele-Norwood D, Zhou P, Clark DA, Riddell R, Maric R, Podack ER, Croitoru K.

Gut. 2002 Aug;51(2):155-63.

41.

Getting to the guts of immune regulation.

Bilsborough J, Viney JL.

Immunology. 2002 Jun;106(2):139-43. Review. No abstract available.

42.
43.

Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1a-/-) mice.

Maggio-Price L, Shows D, Waggie K, Burich A, Zeng W, Escobar S, Morrissey P, Viney JL.

Am J Pathol. 2002 Feb;160(2):739-51.

44.

Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice.

Burich A, Hershberg R, Waggie K, Zeng W, Brabb T, Westrich G, Viney JL, Maggio-Price L.

Am J Physiol Gastrointest Liver Physiol. 2001 Sep;281(3):G764-78.

45.

Immune fate decided by dendritic cell provocateurs.

Viney JL.

Trends Immunol. 2001 Jan;22(1):8-10. No abstract available.

PMID:
11334031
46.

The ins and outs of body surface immunology.

Hayday A, Viney JL.

Science. 2000 Oct 6;290(5489):97-100. Review.

PMID:
11021807
47.

Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice.

Kennedy MK, Glaccum M, Brown SN, Butz EA, Viney JL, Embers M, Matsuki N, Charrier K, Sedger L, Willis CR, Brasel K, Morrissey PJ, Stocking K, Schuh JC, Joyce S, Peschon JJ.

J Exp Med. 2000 Mar 6;191(5):771-80.

48.

Dendritic cell subsets: the ultimate T cell differentiation decision makers?

Viney JL.

Gut. 1999 Nov;45(5):640-1. No abstract available.

49.

Modulating dendritic cells to optimize mucosal immunization protocols.

Williamson E, Westrich GM, Viney JL.

J Immunol. 1999 Oct 1;163(7):3668-75.

50.

Visualizing the T-cell response elicited by oral administration of soluble protein antigen.

Williamson E, O'Malley JM, Viney JL.

Immunology. 1999 Aug;97(4):565-72.

Supplemental Content

Support Center